ARTERYS

San Francisco, CA, USA  All United States companies → — Founded 2011
Imaging AI Specialist
Cardiology Neurology Oncology Radiology
Cardiology AI Oncology AI Radiology & Imaging AI
Series C — $70.2M
Claim this company

Products

Arterys Oncology DL
Arterys
Oncology AI
Arterys Oncology DL is an FDA-cleared, AI-powered cloud-based medical imaging software that automates the segmentation and tracking of lung and liver lesions in CT and MRI scans, enhancing diagnostic efficiency and accuracy for oncologists.
Custom plan
Arterys MICA
Arterys
Radiology & Imaging AI
Arterys MICA is a cloud-based AI platform for medical imaging analysis, designed for radiologists and clinicians to enhance diagnostic processes with automated image analysis, real-time collaboration, and scalable cloud computing for various modalities like CT and MRI.
Contact vendor for pricing
Arterys Cardio DL
ARTERYS
Cardiology AI
Arterys Cardio DL is an FDA-cleared, cloud-based AI software that provides automated, editable ventricle segmentations for cardiac MRI analysis, drastically reducing interpretation time and enhancing diagnostic accuracy.
Contact for pricing

See all 3 products →

About ARTERYS

Arterys is a leading healthcare AI company that has developed a cloud-based platform for advanced medical imaging analysis. For physicians, this platform integrates AI clinical applications directly into existing Picture Archiving and Communication Systems (PACS) or Electronic Health Record (EHR) workflows, aiming to make AI a seamless extension of current diagnostic practices. The company’s core mission is to transform radiology by addressing significant challenges such as heavy radiologist workloads, inconsistencies in diagnostic accuracy, and the need for greater efficiency and precision in medical imaging.

The Arterys platform leverages deep learning and cloud computation to enhance clinician workflow, providing faster and more accurate analysis of various medical images, including MRI, CT, X-ray, and ultrasound. It has received multiple FDA clearances and CE markings, operating in numerous countries globally. The solutions are designed to improve physician experience, diagnostic accuracy, treatment planning, financial performance, and ultimately, patient outcomes across a range of sub-specialties.

Focus Areas

Medical imaging analysis Cardiac MRI Lung CT Liver CT/MRI Neuro-radiology Breast AI Oncology Stroke detection Fracture detection Deep learning Cloud computing AI-powered workflow solutions

Business Intelligence

Key InvestorsTemasek, Benslie Investment Group, GE Ventures, Stanford-StartX Fund, Norwich Ventures, Emergent Medical Partners, Asset Management Ventures, AME Cloud Ventures, Fosun, Revelation Partners, Varian Medical Systems, Northwell Health Ventures, NewYork-Presbyterian, DNA Capital, ORI Capital, Morado Ventures
PartnershipsGE Healthcare (ViosWorks), Premier Inc., iCAD, Amazon HealthLake Imaging, Avicenna.AI, Whiterabbit.ai
AcquisitionsAcquired by Tempus AI on October 3, 2022
TechnologyCloud-native, web-enabled AI medical imaging platform, deep learning, integrates with PACS/EHR for real-time image interpretation and analysis
FDA Clearances8 cleared products (estimated)

What Physicians Need to Know

Medical Imaging Analysis Platform
Arterys offers a comprehensive AI platform for medical imaging analysis, integrating leading AI clinical applications directly into existing PACS or EHR workflows. It supports multiple modalities including MRI, CT, X-ray, and ultrasound.
Cardiac MRI
Their Cardio AI solution provides AI-assisted post-processing for cardiac MRI, enabling quantification of 4D flow, ventricular function volumes, 2D flow, delayed enhancement, perfusion, and T1/T2/T2* mapping. It automates tedious tasks, reducing analysis time significantly (e.g., 30-60 min to 10 min for some scans), and offers precise and consistent ventricular function analysis.
Lung CT
Lung AI assists with chest CT analysis, including lung nodule analysis with longitudinal tracking and volumetric segmentation. It standardizes reporting using integrated Lung-RADS workflow and aids in the diagnosis and follow-up of lung cancer.
Liver CT/MRI
Liver AI efficiently measures and tracks liver lesions, offering visualization, longitudinal tracking, and faster volumetric segmentation with integrated LI-RADS workflow.
Neuro-radiology
Neuro AI provides AI-assisted software for stroke detection on CT, automatically detecting and prioritizing acute Intracranial Hemorrhage (ICH) and Large Vessel Occlusions (LVOs) within seconds. It also supports brain tumor diagnostics on MR, non-invasively distinguishing tumor from necrosis, and quantification/monitoring of white matter lesions.
Breast AI
Breast AI offers innovative solutions for breast cancer detection, breast density measurement, and personalized risk assessment. It uses deep learning to detect soft tissue densities and calcifications in 3D DBT slices, and can identify priority studies.
Oncology
Arterys' Oncology AI suite helps clinicians measure and track tumors or potential cancers, with initial deep learning workflows for liver MRI/CT and lung CT scans. It automates segmentation and tracking of lesions, enhancing diagnostic efficiency and accuracy.
Stroke Detection
Neuro AI automatically detects and prioritizes acute ICH and LVO cases from CT scans, alerting the care team within 20 seconds to expedite patient care in neurovascular emergencies.
Fracture Detection
Their Chest MSK AI automatically detects seven common abnormalities on emergency department X-rays, including fracture, dislocation, elbow joint effusion, pleural effusion, pulmonary nodule, pulmonary opacity, and pneumothorax.
Deep Learning & AI-powered Workflow Solutions
Arterys leverages deep learning and AI algorithms to automate time-consuming analyses, segmentations, and measurements, improving diagnostic accuracy, efficiency, and consistency across various imaging modalities.
Cloud Computing
The Arterys platform is 100% web-based and cloud-native, allowing access from anywhere on any validated device. It uses cloud computation (e.g., AWS) for faster performance, ease of deployment, and real-time data sharing and collaboration without PHI exchange.
Physician Tip

Arterys stands out for physicians by significantly enhancing workflow efficiency and diagnostic accuracy. Its AI-powered, cloud-native platform automates tedious manual tasks like segmentation and quantification, freeing up radiologists' time to focus on complex cases and patient interaction. Physicians can access advanced visualization and AI insights from anywhere, facilitating real-time collaboration and remote reading. The platform provides objective, quantitative data and standardized reporting (e.g., Lung-RADS, LI-RADS), reducing inter-observer variability and supporting more informed clinical decision-making. For patients, this translates to faster diagnoses, reduced scan times (especially beneficial for children), and improved outcomes.

Arterys' platform is designed for seamless integration with existing hospital systems, including Picture Archiving and Communication Systems (PACS) and Electronic Health Records (EHRs), as well as Radiology Information Systems (RIS) and dictation solutions. This allows AI-powered insights to be woven directly into a physician's normal diagnostic workflow without disruption.

Products by ARTERYS

3 products in the directory

Arterys Oncology DL
Arterys
Oncology AI
Arterys Oncology DL is an FDA-cleared, AI-powered cloud-based medical imaging software that automates the segmentation and tracking of lung and liver lesions in CT and MRI scans, enhancing diagnostic efficiency and accuracy for oncologists.
Custom plan
Arterys MICA
Arterys
Radiology & Imaging AI
Arterys MICA is a cloud-based AI platform for medical imaging analysis, designed for radiologists and clinicians to enhance diagnostic processes with automated image analysis, real-time collaboration, and scalable cloud computing for various modalities like CT and MRI.
Contact vendor for pricing
Arterys Cardio DL
ARTERYS
Cardiology AI
Arterys Cardio DL is an FDA-cleared, cloud-based AI software that provides automated, editable ventricle segmentations for cardiac MRI analysis, drastically reducing interpretation time and enhancing diagnostic accuracy.
Contact for pricing

Reviews & Opinions

No web reviews on file yet for ARTERYS. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about ARTERYS.

Loading videos...

Videos load interactively. If none appear, search YouTube for ARTERYS →

View all on YouTube

Press & Coverage

PR Newswire
Arterys Raises $28 Million to Accelerate the Delivery of Medical AI to Practices Around the World
Arterys announced a $28 million Series C funding round led by Benslie Investment Group and Temasek Holdings, alongside its seventh USA FDA clearance. The funding aims to expand the Arterys ecosystem and accelerate the integration of AI into clinical workflows.
2020-05
GlobeNewswire
Arterys Receives Its Eighth FDA Clearance Powered With AI and Releases Its Next-Generation Cardio AI Application
Arterys announced its eighth FDA clearance for its Cardio AI clinical application, which includes new modules leveraging AI and deep learning for accurate and automated analysis of cardiac MRI images. The enhancements aim to streamline physician workflows and improve diagnostic decisions.
2022-04
Newswire.com
Arterys Awarded Artificial Intelligence Solutions for Healthcare Agreement With Premier, Inc.
Arterys secured a national group purchasing agreement with Premier Inc., allowing Premier members to access special pricing for Arterys' medical imaging platform and clinical AI workflow solutions. This agreement aims to provide radiology departments with AI-enhanced tools to improve efficiency and patient care.
2022-11
Tempus
Blogu2014Welcome Arterys: integrating medical imaging insights to drive better outcomes for patients - Tempus
Tempus announced the integration of Arterys' AI platform into its solutions, rebranding it as Tempus Radiology. This collaboration aims to provide a comprehensive patient view, including radiology scans, and leverage AI for precision medicine and drug development.
2023-02
Imaging Technology News
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Arterys received its fifth 510(k) clearance from the FDA for its Oncology AI Suite, a cloud-based medical imaging software. This software assists clinicians in measuring and tracking tumors in liver MRI/CT and lung CT scans, aiming to improve efficiency and accuracy in cancer diagnosis and treatment.
2018-02
DAIC
Arterys Cardio DL Cloud MRI Analytics Software Receives FDA Clearance
Arterys received 510(k) clearance from the FDA for its Arterys Cardio DL application, the first technology to leverage cloud computing and deep learning in a clinical setting for cardiac MRI analysis. This software provides automated ventricle segmentations as accurate as manual methods.
2017-01
MedTech Innovator
Arterys Launches the First Viewer-Based AI Marketplace for Medical Imaging, Fueling Open Innovation
Arterys debuted its open innovation platform, the Arterys Marketplace, at RSNA 2019, making medical imaging AI accessible globally via the internet. This platform allows users to build and distribute AI applications for radiologists quickly.
2019-12
WORLD INTERNATIONAL CONFERENCE ON SCIENCE, TECHNOLOGY AND EDUCATION
ARTERYS CLOUD-BASED AI PLATFORM: APPLICATIONS IN MEDICAL IMAGING AND CLINICAL EFFECTIVENESS.
This peer-reviewed article discusses Arterys as an innovative cloud-based AI platform that automates image processing in radiology and cardiology, aiming to save physicians time and reduce diagnostic errors by digitizing traditional methods.
2026-02

Frequently Asked Questions

ARTERYS, now Tempus Radiology, provides AI-powered, cloud-based solutions for various medical imaging analyses. These include Cardio AI for cardiac MRI, Lung AI for chest CT, Liver AI (part of Oncology AI) for liver CT/MRI, Neuro AI for stroke detection and neurodegenerative diseases, Breast AI for breast cancer detection, and Chest/MSK AI for fracture detection on X-rays.
ARTERYS solutions are designed to be HIPAA- and EU GDPR-compliant, ensuring patient data privacy and security. The company has secured multiple FDA clearances and CE Marks for its various AI applications, demonstrating adherence to rigorous regulatory standards for clinical use.
ARTERYS primarily operates on a Software-as-a-Service (SaaS) subscription model, offering custom plans tailored to institutional needs. While specific pricing is not publicly disclosed, partnerships like the one with Premier Inc. allow members to access special pre-negotiated pricing and terms.
ARTERYS offers online support and provides basic support as part of its subscription plans, with contact information available for customer inquiries. Its cloud-based platform is designed for seamless integration with existing PACS, EHR, and RIS environments, enabling clinicians to weave AI applications directly into their current workflows without additional hardware.
ARTERYS has established significant partnerships, including with GE Healthcare to integrate its system into MRI machines and with Ambra Health for seamless AI application interoperability. Additionally, it partnered with AMG Medtech for sales and marketing in the UK and Ireland, and has a group purchasing agreement with Premier Inc.
ARTERYS, founded in 2011/2012, has demonstrated strong company stability through significant funding rounds, raising over $70 million. The company was acquired by Tempus, a leading technology company in precision medicine, and now operates as Tempus Radiology, indicating a robust and integrated future within a larger healthcare technology entity.
ARTERYS' platform is built on deep learning and cloud computing, utilizing an elastic cloud GPU architecture to accelerate the performance of tasks like 3D rendering and real-time AI application execution. This approach streamlines and speeds up the analysis of medical images, allowing clinicians to access and process large datasets from anywhere with a web browser.

Comparisons

Arterys Cardio DL vs EchoNext
Arterys Cardio DL vs PMcardio
Arterys Cardio DL vs KardiaPro
Arterys Cardio DL vs KardiaPro

Related Companies

CAIMed (Niedersächsisches Zentrum für KI und Kausale Methoden in der Medizin)
Hannover, Germany (Lower Saxony region)

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm
Berkeley, United States and London, United Kingdom. European office in Barcelona, Spain and Gothenburg, Sweden.

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA
London, UK

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics
London, United Kingdom

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI
Canberra, ACT, Australia

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART
Boizenburg / Elbe, Germany

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]
Suggest an Edit →
AI Tool Finder
AI-powered search. Results may not be comprehensive.